이 에피소드에 관해
Gleb Kuznetsov talks about about ditching Google for grad school, what it takes to build a true platform company, and where AI-driven drug discovery is headed.
영어
미국
전사 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
이 팟캐스트의 다른 에피소드
Patrick Hsu reflects on the early days of CRISPR, the power of mentorship, and how AI and open science will reshape the future of research.
(00:00) Introduction to Patrick Hsu
(01:06) Realizing how big CRISPR would become
(06:20) Why Feng Zhang's lab is so high-impact
(14:23) How to spot a breakthr…
Karen Akinsanya unpacks the rise of computational drug discovery, what it takes to prove impact of new technologies, and the importance of setting realistic expectations for AI.
(00:00) Introduction to Karen Akinsanya
(01:54) Pursuing big technological shifts
(06:24) How computation is setting the …
Andrew Bellinger discusses what it takes to build new drug modalities from scratch, the bold bets and tough calls that shaped Verve’s journey, and lessons in building new companies from first-in-class science.
* Editor's note: The interview was recorded following the announcement of Verve's acquisi…
Sara Kenkare-Mitra talks about resilience, risk, and the kind of leadership it takes to save failing drug programs — and make medicines that matter.
(00:00) Introduction to Sara Kenkare-Mitra
(00:36) Turning a (nearly) failed program into a bestselling drug
(08:33) Learning from industry legends
(2…
Jake Becraft reflects on making bold bets in mRNA, the journey from lab bench to biotech founder, and the state of science today.
(00:00) Introduction to Jake Becraft
(00:39) Betting big on mRNA — before it was a proven modality
(11:34) Getting your drugs to patients
(25:47) The state of modern bio…
면책 조항: 이 페이지에 포함된 팟캐스트와 작품은 Benchling에서 가져온 것입니다. 이 팟캐스트는 소유자의 재산이며 Listen Notes, Inc.와 제휴하거나 보증하지 않습니다.
